Elevance Health, Inc.
ELV
$448.43
-$4.26-0.94%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.40% | 8.51% | 10.06% | 11.21% | 13.44% |
| Total Other Revenue | 21.82% | 19.41% | 17.71% | 11.89% | 10.02% |
| Total Revenue | 9.41% | 10.03% | 11.12% | 11.31% | 12.95% |
| Cost of Revenue | 6.59% | 8.08% | 9.71% | 11.22% | 13.64% |
| Gross Profit | 17.65% | 15.71% | 15.25% | 11.57% | 11.00% |
| SG&A Expenses | 15.67% | 18.18% | 17.75% | 15.07% | 15.40% |
| Depreciation & Amortization | 15.38% | 39.69% | 63.96% | 78.16% | 73.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.52% | 10.29% | 11.56% | 12.24% | 14.20% |
| Operating Income | 25.02% | 5.84% | 4.13% | -2.63% | -5.17% |
| Income Before Tax | 1.51% | -2.46% | 5.21% | -1.76% | -4.10% |
| Income Tax Expenses | 0.70% | -5.33% | 6.33% | -2.60% | -6.45% |
| Earnings from Continuing Operations | 1.75% | -1.61% | 4.88% | -1.51% | -3.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -166.67% | -236.67% | -178.13% | -190.48% | -33.33% |
| Net Income | 1.58% | -2.76% | 3.92% | -2.15% | -3.44% |
| EBIT | 25.02% | 5.84% | 4.13% | -2.63% | -5.17% |
| EBITDA | 21.59% | 7.17% | 7.00% | 1.55% | -0.88% |
| EPS Basic | 3.37% | -1.03% | 5.75% | -0.48% | -1.89% |
| Normalized Basic EPS | 27.58% | 4.79% | 3.44% | -3.12% | -4.86% |
| EPS Diluted | 3.77% | -0.69% | 5.98% | -0.38% | -1.88% |
| Normalized Diluted EPS | 28.20% | 5.16% | 3.64% | -3.08% | -4.90% |
| Average Basic Shares Outstanding | -1.84% | -1.72% | -1.66% | -1.62% | -1.58% |
| Average Diluted Shares Outstanding | -2.20% | -2.08% | -1.88% | -1.71% | -1.61% |
| Dividend Per Share | 15.63% | 15.09% | 14.52% | 13.92% | 13.27% |
| Payout Ratio | 0.12% | 0.16% | 0.08% | 0.14% | 0.15% |
